Funded Startups in Brossard
Brossard, Quebec has seen six disclosed funding events across six sectors since mid-2023, with four of those rounds closing in the first half of 2025.
Brossard, Quebec has seen six disclosed funding events across six sectors since mid-2023, with four of those rounds closing in the first half of 2025. The two largest — CHARBONE Hydrogen's $50M raise in June 2025 and Bitfarms' $50M in April 2025 — account for the majority of disclosed capital, with both classified as Series Unknown round types. Smaller rounds from Diagnos ($1M, February 2025), Quantum eMotion ($2M, January 2025), and Tacora Resources ($1M, June 2023) reflect activity at considerably earlier capital thresholds, though formal stage labels remain undisclosed across all six entries.
Sector representation is broad relative to the dataset size: energy, blockchain infrastructure, data and analytics, quantum hardware, biotechnology, and manufacturing each appear once. Brossard sits south of Montreal, and the companies here appear to be raising independently rather than as part of a single industry cluster, which makes the city an atypical but consistently active source of funding activity for the 2023–2025 period.
Most recent rounds
6 shownRelated listings
Frequently asked
What are the largest recent rounds among Brossard-based startups?
CHARBONE Hydrogen ($50M, June 2025) and Bitfarms ($50M, April 2025) are the two largest disclosed rounds in this dataset, both closing within a nine-week span. The next largest is Quantum eMotion at $2M in January 2025, marking a substantial gap between the top tier and the rest of the visible deals.
Which sectors have attracted funding in Brossard?
The six visible rounds span energy (CHARBONE Hydrogen), blockchain and cryptocurrency (Bitfarms), data and analytics (Diagnos), hardware (Quantum eMotion), biotechnology (Mantra Pharma), and manufacturing (Tacora Resources). No single sector accounts for more than one round in the current dataset.
How active has funding been in Brossard during 2025?
Four of the six rounds closed in 2025 — Quantum eMotion in January, Diagnos in February, Bitfarms in April, and CHARBONE Hydrogen in June. The remaining two rounds date to the second half of 2023, suggesting a meaningful uptick in deal volume entering 2025.
What round stages are Brossard companies raising at?
All six rounds are classified as Series Unknown, meaning no formal stage label (seed, Series A, growth, etc.) has been publicly disclosed for any of the companies shown. This limits stage-based segmentation for the Brossard cohort as currently available.
Are there any rounds with undisclosed amounts, and how does that affect the data picture?
Mantra Pharma's November 2023 round carries no disclosed amount. The remaining five rounds range from $1M to $50M. Excluding Mantra Pharma, the average disclosed round size is skewed heavily by the two $50M raises; the three smaller rounds each fall at or below $2M.
Which Brossard companies would be highest-priority targets for enterprise sales outreach based on round size?
CHARBONE Hydrogen and Bitfarms, each having closed $50M rounds in early-to-mid 2025, represent the highest recent capital deployment in this set and are the most likely to be actively expanding vendor relationships. Quantum eMotion ($2M, January 2025) and Diagnos ($1M, February 2025) are more recently funded but at significantly smaller scale.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.